119 related articles for article (PubMed ID: 6587568)
1. Altered transcription of the c-abl oncogene in K-562 and other chronic myelogenous leukemia cells.
Collins SJ; Kubonishi I; Miyoshi I; Groudine MT
Science; 1984 Jul; 225(4657):72-4. PubMed ID: 6587568
[TBL] [Abstract][Full Text] [Related]
2. An 8-kilobase abl RNA transcript in chronic myelogenous leukemia.
Gale RP; Canaani E
Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5648-52. PubMed ID: 6091099
[TBL] [Abstract][Full Text] [Related]
3. Altered transcription of an oncogene in chronic myeloid leukaemia.
Canaani E; Gale RP; Steiner-Saltz D; Berrebi A; Aghai E; Januszewicz E
Lancet; 1984 Mar; 1(8377):593-5. PubMed ID: 6142307
[TBL] [Abstract][Full Text] [Related]
4. Chronic myelogenous leukemia: amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis.
Collins SJ; Groudine MT
Blood; 1987 Mar; 69(3):893-8. PubMed ID: 3545323
[TBL] [Abstract][Full Text] [Related]
5. Molecular characteristics of chronic myelogenous leukemia in blast crisis.
Blick M; Romero P; Talpaz M; Kurzrock R; Shtalrid M; Andersson B; Trujillo J; Beran M; Gutterman J
Cancer Genet Cytogenet; 1987 Aug; 27(2):349-56. PubMed ID: 3474057
[TBL] [Abstract][Full Text] [Related]
6. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia.
Shtivelman E; Lifshitz B; Gale RP; Canaani E
Nature; 1985 Jun 13-19; 315(6020):550-4. PubMed ID: 2989692
[TBL] [Abstract][Full Text] [Related]
7. Additional c-abl/bcr rearrangements in a CML patient exhibiting two ph1 chromosomes during blast crisis.
Bartram CR; de Klein A; Hagemeijer A; Carbonell F; Kleihauer E; Grosveld G
Leuk Res; 1986; 10(2):221-5. PubMed ID: 3005778
[TBL] [Abstract][Full Text] [Related]
8. C-sis and C-abl expression in chronic myelogenous leukemia and other hematologic malignancies.
Romero P; Blick M; Talpaz M; Murphy E; Hester J; Gutterman J
Blood; 1986 Mar; 67(3):839-41. PubMed ID: 3456250
[TBL] [Abstract][Full Text] [Related]
9. Expression of a translocated c-abl gene in hybrids of mouse fibroblasts and chronic myelogenous leukaemia cells.
Kozbor D; Giallongo A; Sierzega ME; Konopka JB; Witte ON; Showe LC; Croce CM
Nature; 1986 Jan 23-29; 319(6051):331-3. PubMed ID: 3455750
[TBL] [Abstract][Full Text] [Related]
10. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia.
de Klein A; van Kessel AG; Grosveld G; Bartram CR; Hagemeijer A; Bootsma D; Spurr NK; Heisterkamp N; Groffen J; Stephenson JR
Nature; 1982 Dec; 300(5894):765-7. PubMed ID: 6960256
[TBL] [Abstract][Full Text] [Related]
11. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene.
Ben-Neriah Y; Daley GQ; Mes-Masson AM; Witte ON; Baltimore D
Science; 1986 Jul; 233(4760):212-4. PubMed ID: 3460176
[TBL] [Abstract][Full Text] [Related]
12. bcr Rearrangement without juxtaposition of c-abl in chronic myelocytic leukemia.
Bartram CR
J Exp Med; 1985 Dec; 162(6):2175-9. PubMed ID: 2415665
[TBL] [Abstract][Full Text] [Related]
13. Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562.
Collins SJ; Groudine MT
Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4813-7. PubMed ID: 6308652
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia.
Daniel L; Ahmed CM; Bloodgood RS; Kidd JR; Castiglione CM; Duttagupta S; Lebowitz P
Oncogene; 1987 May; 1(2):193-200. PubMed ID: 2894000
[TBL] [Abstract][Full Text] [Related]
15. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
[TBL] [Abstract][Full Text] [Related]
16. Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration.
Konopka JB; Watanabe SM; Singer JW; Collins SJ; Witte ON
Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1810-4. PubMed ID: 3856862
[TBL] [Abstract][Full Text] [Related]
17. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.
Clark SS; McLaughlin J; Crist WM; Champlin R; Witte ON
Science; 1987 Jan; 235(4784):85-8. PubMed ID: 3541203
[TBL] [Abstract][Full Text] [Related]
18. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
Collins SJ
J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in expression of the bcr-abl fusion transcript in CML blast crisis.
Andrews DF; Collins SJ
Leukemia; 1987 Oct; 1(10):718-24. PubMed ID: 3312834
[TBL] [Abstract][Full Text] [Related]
20. Genomic diversity correlates with clinical variation in Ph'-negative chronic myeloid leukaemia.
Morris CM; Reeve AE; Fitzgerald PH; Hollings PE; Beard ME; Heaton DC
Nature; 1986 Mar 20-26; 320(6059):281-3. PubMed ID: 3007992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
